Decree Law No. 13/2021
- Issuer: Presidency of the Council of Ministers
- Diploma Type: Decree Law
- Number: 13/2021
- Pages: 3 - 19
Summary in plain english
This decree-law creates the National Laboratory for Medicines (LM) and approves its statute.What is going to change?
The LM succeeds the Military Laboratory of Chemical and Pharmaceutical Products (LMPQF).
This restructuring takes place under the responsibility of the Army Chief of Staff (CEME) and covers:
- All operations and decisions necessary for the implementation of the changes in the legal nature;
- The redeployment (transfer) of workers of the LMPQF to the organic framework of the LM;
- The redeployment (transfer) of all other LMPQF resources to the LM.
This decree-law creates a public structure in the area of medicine, promoting research and scientific knowledge. It values the rich experience of the former Military Laboratory of Chemical and Pharmaceutical Products, increasing the resources allocated to it and creating the material and institutional conditions for it to expand its activity. This activity will be relevant for the Armed Forces, but also for other areas of the State, since the new Laboratory will play a role in the areas of health and medicines.
The LM allows for a focus on national production in the medicines sector, ensuring the strategic production of essential medicines, supplying the needs not covered by the pharmaceutical industry.When does it enter into force?
This decree-law enters into force on the day following its publication.
Legal translator is the translation of texts within the field of law